Wulff, Hansen & Co’s Medtronic MDT Stock Holding History

Wulff, Hansen & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,465	Closed	-$441K	–	86
2022 Q3	$441K	Buy	5,465 +100	+2%	+$8.99K	0.55%	54
2022 Q2	$482K	Hold	5,365	–	–	0.55%	53
2022 Q1	$595K	Sell	5,365 -75	-1%	-$7.92K	0.57%	51
2021 Q4	$563K	Buy	+5,440	New	+$630K	0.49%	58

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wulff, Hansen & Co's MDT Position: Q4 2022 in Review

Wulff, Hansen & Co sold out of Medtronic (MDT) in Q4 2022, closing a stake of 5,465 shares — an estimated $441K sold.

Wulff, Hansen & Co first reported a position in MDT in Q4 2021 and held it in 4 quarters. The position peaked at $595K in Q1 2022. 1,961 funds tracked by Wall St. Rank hold MDT as of Q4 2022.

Wulff, Hansen & Co reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
Wulff, Hansen & Co sold 5,465 Medtronic shares in Q4 2022, an estimated $441K.
Wulff, Hansen & Co first reported a position in Medtronic in Q4 2021 and held it in 4 quarters.
Wulff, Hansen & Co's Medtronic position peaked at $595K in Q1 2022.
1,961 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.

Based on Wulff, Hansen & Co's 13F filing for Q4 2022, filed 7 Feb 2023.